The IAEA has recently launched SAFRON for Radionuclide Therapy, an incident learning system to help medical facilities improve safety of patients and staff. The objective of this new learning system ...
After the Fukushima nuclear power plant accident, managing environmental radionuclide contamination efficiently has become incredibly important. In light of this, a team of scientists have provided ...
If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more. Nuclear medicine plays a very important role in the ...
In terms of patient selection, workgroup members agreed that PSMA PET should be performed within three months of treatment or since progression on the last therapy to ensure that the current disease ...
Since its approval in 2018 by the US Food and Drug Administration, peptide receptor radionuclide therapy (PRRT) has become a mainstay in the treatment of neuroendocrine tumors. Lutetium-177-DOTATATE, ...
Radionuclide therapy is an increasingly important modality in the treatment of various malignancies, utilising radiopharmaceuticals to deliver targeted cytotoxic radiation to diseased tissues. Central ...
Prostate cancer is the most common cancer in men and at later stages of the disease many patients develop painful bone metastases. One promising modality for management of skeletal metastases is ...
Transaxial slices of baseline positron emission tomography (PET) and fused PET/magnetic resonance imaging (MRI; left) demonstrate a somatostatin receptor-expressing meningioma in the left cavernous ...
Pancreatic malignancies, the fourth leading cause of cancer deaths, have an aggressive behavior with poor prognosis, resulting in a 5-year survival rate of only 4%. It is typically a silent malignancy ...
If you can get rid of circulating tumor cells and tumor cell clusters that detach from a tumor, spreading the disease in the body, cancer is less likely to return. This is the hope behind a ...
Reston, VA (September 28, 2021)—A promising radionuclide treatment may offer new therapeutic options for breast cancer patients, according to research published in The Journal of Nuclear Medicine. The ...
γ-emitting isotopes are selected for diagnosis because the radiation they produce can be detected by specific instruments such as positron emission tomography (PET) or single-photon emission computed ...